39 results
424B5
MRSN
Mersana Therapeutics Inc
9 May 24
Prospectus supplement for primary offering
5:06pm
, voting together as a single class. This requirement of a supermajority vote to remove directors could enable a minority of our stockholders to prevent … or otherwise attempting to obtain control of the Company.
Supermajority Approval Requirements. The DGCL generally provides that the affirmative vote
424B5
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus supplement for primary offering
4:07pm
% of the voting power of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove … a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of the Company.
Supermajority Approval Requirements
POS AM
MRSN
Mersana Therapeutics Inc
28 Feb 24
Prospectus update (post-effective amendment)
4:05pm
of our outstanding shares of capital stock, voting together as a single class. This requirement of a supermajority vote to remove directors could enable … to elect its own slate of directors or otherwise attempting to obtain control of the Company.
Supermajority Approval Requirements. The DGCL generally
POSASR
3lizm1qxjnbn
28 Feb 24
Automatic shelf registration (post-effective amendment)
8:43am
8-K
oljam
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:25pm
S-3ASR
jv54e
9 May 23
Automatic shelf registration
4:10pm
DEFA14A
yb7k0we5
28 Apr 23
Additional proxy soliciting materials
6:02am
424B5
jvmlell4ruvae47k3uft
7 Nov 22
Prospectus supplement for primary offering
4:03pm
424B5
h02thbwp68ibmuh106tg
28 Feb 22
Prospectus supplement for primary offering
5:12pm